Brancous LP1 has initiated a proxy battle at Braemar Hotels & Resorts Inc. by filing a preliminary proxy statement in connection with the company’s 2026 annual meeting of stockholders. This move is significant as it seeks to elect five new directors to the board, a decision that could reshape the company’s management and strategic direction.

The annual meeting is scheduled for December 21, 2026, and Brancous aims to position its nominees—Oliver Corlette, Ronald Davies, Andrew Fleiss, Michael Litwin, and Alejandro Malbran—against the company’s existing board members. This development comes amid Braemar's recent announcement to terminate its advisory relationship with Ashford Inc., a decision that has sparked considerable debate among stakeholders.

Background

Brancous LP1 is a limited partnership based in Ontario, Canada, and has been a stockholder of Braemar Hotels & Resorts since September 2023. The company operates under the real estate investment trust (REIT) sector, specifically focusing on hotel and resort properties. The recent filing, dated November 4, 2026, is part of a series of actions taken by Brancous to influence the governance of Braemar, which is incorporated in Maryland and has its principal executive offices in Dallas, Texas.

What the Filing Says

In the filing, Brancous states, “We are soliciting proxies to elect five highly qualified director candidates to the Company’s Board of Directors.” The proxy statement emphasizes the need for directors who are independent of Ashford Inc. and the current board members who managed the company’s relationship with Ashford. This independence is seen as crucial for overseeing the company’s transition and future asset sales.

Impact

The outcome of this proxy solicitation could significantly affect Braemar’s governance and operational strategy. If Brancous’s nominees are elected, they may push for a more independent management approach, particularly in light of the recent decision to end ties with Ashford Inc. This could also influence investor confidence and the company's stock performance as it navigates its strategic direction.

What's Next

As the annual meeting approaches, the focus will be on the voting process and the response from Braemar's current board regarding Brancous's nominations. The company has previously indicated that it believes Brancous’s nominations are invalid, which could lead to further legal disputes. The situation is evolving, and stakeholders will be closely monitoring the developments leading up to the meeting.